Zilbrysq

Active Ingredient(s): Zilucoplan
FDA Approved: * October 17, 2023
Pharm Company: * UCB INC
Category: Immunosuppressive
* May have multiple approval dates, manufacturers, or labelers.

Dosage List

Zilbrysq 40 mg/ml Subcutaneous Injection, Solution
NDC: 50474-990
Labeler:
Ucb, Inc.
Zilbrysq 40 mg/ml Subcutaneous Injection, Solution
NDC: 50474-991
Labeler:
Ucb, Inc.
Zilbrysq 40 mg/ml Subcutaneous Injection, Solution
NDC: 50474-992
Labeler:
Ucb, Inc.